Advances in Cervical Cancer Immunotherapy and Prevention Research
Download as PDF
DOI: 10.23977/misbp.2022012
Corresponding Author
Ruichen Ma
ABSTRACT
The incidence of cervical cancer ranks first among malignant tumors of the female reproductive system and is a serious threat to women's health, and in recent years, the incidence of cervical cancer is trending younger. Persistent high-risk human papilloma (HPV) infection is the main risk factor for the development of cervical cancer. Meanwhile, early sexual intercourse, multiple sexual partners, frequent deliveries, pathogen infection, smoking and poor hygiene habits can increase the risk of cervical cancer. Early screening can help detect precancerous lesions and cervical cancer in time. The main methods to deal with cervical cancer are prevention before the onset of the disease and treatment after the onset of the disease. For patients who have been diagnosed with cervical cancer, clinical treatment is mainly surgery and radiotherapy, supplemented by chemotherapy, and the specific treatment plan is mainly based on the patient's tumor stage and mostly adopts comprehensive therapy. This article introduces the prevention, screening and treatment methods of cervical cancer, aiming to provide reference for the prevention and treatment of cervical cancer in clinical practice.
KEYWORDS
Cervical cancer, immunotherapy, vaccine, research progress